Parexel

Parexel offers extensive programs to support the development of women in leadership, engagement of men in enhancing cross-gender partnerships and inclusive leadership skill development, including: 🔹 Forum for Executive Women through WOMEN Unlimited, Inc., The Women's Organization for Mentoring, Education and Networking 🔹 Women in Leadership (WIL) through Linkage, a SHRM Company 🔹 Wisdom Circles 🔹 Change Makers Through these initiatives, we've increased representation of women at the VP-level and above from 33.5% to 45.6% in just 10 years! Learn more about these programs and explore opportunities to grow with us: https://insde.co/egd1 #WomenInLeadership #DiversityAndInclusion #ParexelCareers

ACRO’s latest survey on RBQM adoption reveals a critical insight: centralized monitoring is being underutilized, despite its proven ability to: ✅ Strengthen patient safety oversight ✅ Drive improvements in data quality ACRO’s RBQM Working Group is on a mission to change this. A new paper, co-authored by our own Cris McDavid, walks through a real-world implementation, offering actionable insights for fully realizing the potential of centralized monitoring. 📖 Explore the findings here: https://lnkd.in/e8ms3WQr #RBQM #CentralizedMonitoring #PatientSafety

📊 In our recent LinkedIn poll on diversity in neuroscience, 38% of you said support for patients with cognitive/communication barriers is key, while 35% emphasized broader eligibility criteria. 🧠 We couldn't agree more. Diversity goes beyond demographics ─ it's about inclusivity for all abilities and backgrounds. 🔍 Want to learn more? Check out our Q&A with Xoli Belgrave, Head of Clinical Trial Diversity and Inclusion, on overcoming barriers to diversity in neuroscience trials. https://lnkd.in/gH6kTtf7 #Neuroscience #PatientsFirst #PatientDiversity #NovelInsights

Diversity in clinical trials isn’t nice-to-have—it’s a must-have for ensuring the safety and efficacy of treatments across all patient populations. As Xoli Belgrave explains in Inside Precision Medicine, the path to more inclusive trials starts with patient voices, data-driven insights and intentional site selection. ❓ What steps do you think the industry can take to further ensure diversity and inclusion in clinical trials?

At last week's Bloomberg's AI and Drug Development Forum, Parexel’s Stephen Pyke joined Bloomberg’s VaNae N. Hamilton, Ph.D. and Certara’s Christopher Bouton, Ph.D. for a panel discussion on AI and the Approval/Post-Approval Process. Together they weighed in on the integration of AI into drug development: ✔ What applications already use AI or machine learning elements ✔ Where we need more regulatory guidance ✔ The future of AI-derived biomarker applications and other innovations   💬 Question for our followers: What area of clinical development do you think could benefit most from AI integration, and why? Comment below with your perspective! #AI #DrugDevelopment #Bloomberg

✨Reflecting on Parexel #WeFest2024 ✨   What a blast! Parexel India's "Fast > Future > Forward" event buzzed with energy, enthusiasm and excitement for the year ahead, featuring 🎵 outstanding colleague performances 🏆 "Celebrating Success Awards" for top performers 💪 and excellence, innovation and teamwork on display in many forms.   A heartfelt thank you to everyone who contributed to making this event a success.  As we move forward, let's continue advancing healthcare together — always putting patients first. #ParexelWithHeart #PatientsFirst #ParexelIndia

Despite the hype, psychedelic treatments aren’t shielded from regulatory scrutiny. 🚧 Parexel’s Mwango Kashoki MD MPH says there is a path to regulatory approval, but with the right trial strategies.    Read her recommendations for navigating the challenges in PharmaVoice. ➡ https://lnkd.in/eMfYEEJV

Meet Jo, VP, Consulting, who shares how her FDA background, dedication to patients and strategic approach shape her work at Parexel. Find out how she helps ensure compliance and expedite life-changing treatments ─ and the unexpected connection she draws between regulatory strategy and her knitting hobby! 🧶 Stay tuned for more stories about Parexel's most unique insight-generation engine: our people. https://brnw.ch/21wPtKK #ParexelCareers #Regulatory #Consulting

"Neuroscience trials remain traditional because of the heterogeneity of neurologic, neurodegenerative, and psychiatric diseases and the relative absence of actionable biomarkers. Yet adaptive approaches and biomarkers could optimize trial designs and make development more efficient." In this edition of the New Medicines, Novel Insights newsletter, Parexel experts review recent advances in the field, including the emergence of new blood and imaging biomarkers in Alzheimer’s disease (AD), multiple sclerosis (MS), and major depressive disorders (MDD), suggest the time has come for invention and cross-fertilization. Our newsletter will be taking a short two-week break for the holidays as our team recharges for a new year of clinical trial innovation in 2025! 💫🎆 Be sure to subscribe for industry leading #NovelInsights delivered to you weekly in the new year. #Neurology #Neuroscience #NeuroscienceTrials #NeuroscienceResearch 

📣 Parexel is seeking experienced Clinical Operations Leaders and Clinical Trial Managers! 📣 We're looking for someone to: 🔬 Bring a strong background in clinical operations (CRA, Startup, etc.). 🚀 Independently lead global studies. 💼 Excel in budget management. 🤝 Thrive in a collaborative, fast-paced environment.   At Parexel, we tackle complex global projects on time with quality from the start, while working as one team. Your expertise can help us bring medicines to patients faster. Apply today. 👉 https://insde.co/2dec #ParexelCareers #ClinicalResearchJobs